6GS4 image
Entry Detail
PDB ID:
6GS4
Title:
Crystal structure of peptide transporter DtpA-nanobody in complex with valganciclovir
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2018-06-13
Release Date:
2019-01-30
Method Details:
Experimental Method:
Resolution:
2.65 Å
R-Value Free:
0.23
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Dipeptide and tripeptide permease A
Chain IDs:A
Chain Length:508
Number of Molecules:1
Biological Source: Escherichia coli K-12
Polymer Type:polypeptide(L)
Description:nanobody
Chain IDs:B (auth: H)
Chain Length:132
Number of Molecules:1
Biological Source:Lama glama
Primary Citation
Structure of Prototypic Peptide Transporter DtpA from E. coli in Complex with Valganciclovir Provides Insights into Drug Binding of Human PepT1.
J. Am. Chem. Soc. 141 2404 2412 (2019)
PMID: 30644743 DOI: 10.1021/jacs.8b11343

Abstact

Members of the solute carrier 15 family (SLC15) transport di- and tripeptides as well as peptidomimetic drugs across the cell membrane. Structures of bacterial homologues have provided valuable information on the binding and transport of their natural substrates, but many do not transport medically relevant drugs. In contrast, a homologue from Escherichia coli, DtpA (dipeptide and tripeptide permease), shows a high similarity to human PepT1 (SLC15A1) in terms of ligand selectivity and transports a similar set of drugs. Here, we present the crystal structure of DtpA in ligand-free form (at 3.30 Å resolution) and in complex with the antiviral prodrug valganciclovir (at 2.65 Å resolution) supported by biochemical data. We show that valganciclovir unexpectedly binds with the ganciclovir moiety mimicking the N-terminal residue of a canonical peptide substrate. On the basis of a homology model we argue that this binding mode also applies to the human PepT1 transporter. Our results provide new insights into the binding mode of prodrugs and will assist the rational design of drugs with improved absorption rates.

Legend

Protein

Chemical

Disease

Primary Citation of related structures